Tisotumab Vedotin: The First FDA-Approved Antibody-Drug Conjugate for Cervical Cancer

De, SK

De, SK (通讯作者)，Conju Probe, San Diego, CA 92121 USA.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022; 22 (16): 2808

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索